The role of growth factors in the pathogenesis of diabetic retinopathy
- 1 October 2004
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 13 (10) , 1275-1293
- https://doi.org/10.1517/13543784.13.10.1275
Abstract
Diabetic retinopathy (DR) is the most severe of several ocular complications of diabetes. The earliest clinical signs of DR are microaneurysms and haemorrhages. Later signs include dilated, tortuous irregular veins and retinal non-profusion, leading to retinal ischaemia that ultimately results in neovascularisation. Diabetic macular oedema, which involves the breakdown of the blood–retinal barrier, also occurs and is responsible for a major part of vision loss, particularly in Type 2 diabetes. The pathogenesis of DR is very complex. Many biochemical mechanisms have been proposed as explanations for the development and progression of DR. Chronic hyperglycaemia leads to oxidative injury, microthrombi formation, cell adhesion molecule activation, leukostasis and cytokine activation. Next, ischaemia-mediated overexpression of growth factors and cytokines occurs. These factors include vascular endothelial growth factor, insulin-like growth factor-1, angiopoetin-1 and -2, stromal-derived factor-1, fibroblast gr...Keywords
This publication has 103 references indexed in Scilit:
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Reversion of ‘Early Worsening’ of Diabetic Retinopathy by Deliberate Restoration of Poor Metabolic ControlOphthalmologica, 2003
- Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signalingThe Journal of cell biology, 2002
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- Microvascular Permeability is Increased in Both Types of Diabetes and Correlates Differentially with Serum Levels of Insulin-Like Growth Factor I (IGF-I) and Vascular Endothelial Growth Factor (VEGF)Hormone and Metabolic Research, 2001
- Use of Quantitative TaqMan Real-Time PCR to Track the Time-Dependent Distribution of Gene Transfer Vectors in VivoMolecular Therapy, 2000
- Systemic Levels Contribute Significantly to Increased Intraocular IGF-I, IGF-II and IFG-BP3 in Proliferative Diabetic RetinopathyHormone and Metabolic Research, 2000
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Insulin-like Growth FactorsNew England Journal of Medicine, 1983
- A Follow-up Study of Vascular Disease in Growth-Hormone-Deficient Dwarfs with DiabetesNew England Journal of Medicine, 1978